1ty7: Difference between revisions
New page: left|200px<br /> <applet load="1ty7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1ty7, resolution 3.10Å" /> '''Structural basis fo... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1ty7.gif|left|200px]]<br /> | [[Image:1ty7.gif|left|200px]]<br /><applet load="1ty7" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1ty7" size=" | |||
caption="1ty7, resolution 3.10Å" /> | caption="1ty7, resolution 3.10Å" /> | ||
'''Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen'''<br /> | '''Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen'''<br /> | ||
==Overview== | ==Overview== | ||
Integrins are important adhesion receptors in all Metazoa that transmit | Integrins are important adhesion receptors in all Metazoa that transmit conformational change bidirectionally across the membrane. Integrin alpha and beta subunits form a head and two long legs in the ectodomain and span the membrane. Here, we define with crystal structures the atomic basis for allosteric regulation of the conformation and affinity for ligand of the integrin ectodomain, and how fibrinogen-mimetic therapeutics bind to platelet integrin alpha(IIb)beta3. Allostery in the beta3 I domain alters three metal binding sites, associated loops and alpha1- and alpha7-helices. Piston-like displacement of the alpha7-helix causes a 62 degrees reorientation between the beta3 I and hybrid domains. Transmission through the rigidly connected plexin/semaphorin/integrin (PSI) domain in the upper beta3 leg causes a 70 A separation between the knees of the alpha and beta legs. Allostery in the head thus disrupts interaction between the legs in a previously described low-affinity bent integrin conformation, and leg extension positions the high-affinity head far above the cell surface. | ||
==Disease== | ==Disease== | ||
Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1TY7 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with NAG, NDG, MG, CA, 180 and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | 1TY7 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=NDG:'>NDG</scene>, <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=CA:'>CA</scene>, <scene name='pdbligand=180:'>180</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1TY7 OCA]. | ||
==Reference== | ==Reference== | ||
Line 18: | Line 17: | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: Coller, B | [[Category: Coller, B S.]] | ||
[[Category: Springer, T | [[Category: Springer, T A.]] | ||
[[Category: Takagi, J.]] | [[Category: Takagi, J.]] | ||
[[Category: Wang, J | [[Category: Wang, J H.]] | ||
[[Category: Xiao, T.]] | [[Category: Xiao, T.]] | ||
[[Category: 180]] | [[Category: 180]] | ||
Line 31: | Line 30: | ||
[[Category: crystal structure; platelet integrin alphaiibbeta3; fibrinogen binding; allostery; therapeutic antagonism]] | [[Category: crystal structure; platelet integrin alphaiibbeta3; fibrinogen binding; allostery; therapeutic antagonism]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:18:40 2008'' |
Revision as of 16:18, 21 February 2008
|
Structural basis for allostery in integrins and binding of ligand-mimetic therapeutics to the platelet receptor for fibrinogen
OverviewOverview
Integrins are important adhesion receptors in all Metazoa that transmit conformational change bidirectionally across the membrane. Integrin alpha and beta subunits form a head and two long legs in the ectodomain and span the membrane. Here, we define with crystal structures the atomic basis for allosteric regulation of the conformation and affinity for ligand of the integrin ectodomain, and how fibrinogen-mimetic therapeutics bind to platelet integrin alpha(IIb)beta3. Allostery in the beta3 I domain alters three metal binding sites, associated loops and alpha1- and alpha7-helices. Piston-like displacement of the alpha7-helix causes a 62 degrees reorientation between the beta3 I and hybrid domains. Transmission through the rigidly connected plexin/semaphorin/integrin (PSI) domain in the upper beta3 leg causes a 70 A separation between the knees of the alpha and beta legs. Allostery in the head thus disrupts interaction between the legs in a previously described low-affinity bent integrin conformation, and leg extension positions the high-affinity head far above the cell surface.
DiseaseDisease
Known diseases associated with this structure: Glanzmann thrombasthenia, type A OMIM:[607759], Glanzmann thrombasthenia, type B OMIM:[173470], Thrombocytopenia, neonatal alloimmune OMIM:[607759]
About this StructureAbout this Structure
1TY7 is a Protein complex structure of sequences from Homo sapiens and Mus musculus with , , , , and as ligands. Full crystallographic information is available from OCA.
ReferenceReference
Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics., Xiao T, Takagi J, Coller BS, Wang JH, Springer TA, Nature. 2004 Nov 4;432(7013):59-67. Epub 2004 Sep 19. PMID:15378069
Page seeded by OCA on Thu Feb 21 15:18:40 2008